Zhengzhou Deep Blue Sea

Zhengzhou Deep Blue Sea is a leading Chinese Contract Research Organization (CRO) that provides comprehensive clinical research services to the pharmaceutical and medical device industries. As a subsidiary of Tigermed, the company specializes in clinical trial management, data management, biostatistics, and regulatory affairs. It operates primarily within China, offering localized expertise to help domestic and international clients navigate the complex regulatory landscape for drug approval. The company is recognized for its robust quality management systems and its ability to execute large-scale clinical trials across various therapeutic areas. By leveraging its integration with the Tigermed network, it provides end-to-end solutions from Phase I through Phase IV clinical development.